Driving Therapeutic Innovation in Neurodegenerative Disease with Hydrogen Deuterium eXchange Mass Spectrometry
Pierangelini A. et al, (2025), Molecular & Cellular Proteomics, 101017 - 101017
Effect of a Laparoscopic Donor Nephrectomy in Healthy Living Kidney Donors on the Acute Phase Response Using Either Propofol or Sevoflurane Anesthesia
Brattinga B. et al, (2025), International Journal of Molecular Sciences, 26, 5196 - 5196
Characterization of ADAMTS9 proteoglycanase activity: comparison with ADAMTS1, ADAMTS4 and ADAMTS5.
Martin DR. et al, (2025), The Journal of biological chemistry
Integrative proximal-ubiquitomics profiling for deubiquitinase substrate discovery applied to USP30
Damianou A. et al, (2025), Cell Chemical Biology
Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma
Furqan M. et al, (2025), Pharmaceutics, 17, 549 - 549
Activity-based protein profiling reveals both canonical and novel ubiquitin pathway enzymes in Plasmodium
Smith C. et al, (2025), PLOS Pathogens, 21, e1013032 - e1013032
A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014–present)
Aiken SG. et al, (2025), Expert Opinion on Therapeutic Patents, 1 - 11
Single-nucleus multi-omics implicates androgen receptor signaling in cardiomyocytes and NR4A1 regulation in fibroblasts during atrial fibrillation
Leblanc FJA. et al, (2025), Nature Cardiovascular Research
Drug repurposing in amyotrophic lateral sclerosis (ALS)
Carroll E. et al, (2025), Expert Opinion on Drug Discovery, 1 - 18
Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
Scott HC. et al, (2025), Journal of Endocrinology and Metabolism, 15, 1 - 14
Pharmacological targeting of BMAL1 modulates circadian and immune pathways.
Pu H. et al, (2025), Nature chemical biology
ATR-hippo drives force signaling to nuclear F-actin and links mechanotransduction to neurological disorders
Chatzifrangkeskou M. et al, (2025), Science Advances, 11
HIF2α: the interface between oxygen-sensing systems in physiology and pathology
Bishop T. and Ratcliffe PJ., (2025), Physiology
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
O’Brien DP. et al, (2025), Journal of Proteome Research, 24, 479 - 490
Allosteric communications between domains of nuclear receptors.
Rastinejad F., (2025), Steroids, 214
LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity.
Loh NY. et al, (2025), Communications medicine, 5
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
Li HZ. et al, (2025), Nature Communications, 16
Activity-Based Protein Profiling (ABPP) of Cellular DeISGylating Enzymes and Inhibitor Screening.
Draganov SD. et al, (2025), Methods in molecular biology (Clifton, N.J.), 2921, 1 - 29
Conserved patterns of transcriptional dysregulation, heterogeneity, and cell states in clear cell kidney cancer.
Lombardi O. et al, (2025), Cell reports, 44